- Home
- HQI vs KRRO Comparison
HQI vs KRRO Comparison
Compare HQI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- KRRO
- Stock Information
- Founded
- HQI 2002
- KRRO 2014
- Country
- HQI United States
- KRRO United States
- Employees
- HQI N/A
- KRRO N/A
- Industry
- HQI Professional Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- HQI Consumer Discretionary
- KRRO Health Care
- Exchange
- HQI Nasdaq
- KRRO Nasdaq
- Market Cap
- HQI 196.4M
- KRRO 209.6M
- IPO Year
- HQI N/A
- KRRO 2019
- Fundamental
- Price
- HQI $12.37
- KRRO $17.34
- Analyst Decision
- HQI Strong Buy
- KRRO Strong Buy
- Analyst Count
- HQI 2
- KRRO 7
- Target Price
- HQI $17.50
- KRRO $132.17
- AVG Volume (30 Days)
- HQI 17.6K
- KRRO 112.8K
- Earning Date
- HQI 03-27-2025
- KRRO 03-18-2025
- Dividend Yield
- HQI 1.98%
- KRRO N/A
- EPS Growth
- HQI N/A
- KRRO N/A
- EPS
- HQI 0.26
- KRRO N/A
- Revenue
- HQI $34,598,000.00
- KRRO $2,271,000.00
- Revenue This Year
- HQI $8.49
- KRRO N/A
- Revenue Next Year
- HQI $0.63
- KRRO N/A
- P/E Ratio
- HQI $45.90
- KRRO N/A
- Revenue Growth
- HQI N/A
- KRRO N/A
- 52 Week Low
- HQI $11.39
- KRRO $15.16
- 52 Week High
- HQI $15.75
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- HQI 40.08
- KRRO 33.76
- Support Level
- HQI $11.67
- KRRO $15.16
- Resistance Level
- HQI $13.76
- KRRO $25.25
- Average True Range (ATR)
- HQI 0.57
- KRRO 2.90
- MACD
- HQI -0.12
- KRRO -0.26
- Stochastic Oscillator
- HQI 33.18
- KRRO 16.35
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.